Abstract:Context: Obstructive sleep apnea (OSA) has been increasingly implicated in the initiation and progression of cardiovascular diseases. Objective: To systematically review the interactions of OSA with cardiovascular pathophysiology and diseases. Data sources and study selection: The MEDLINE database from January 1966 to March 2003 was searched using the Medical Subject Headings sleep, sleep apnea, obesity, hypertension, heart failure, cardiac arrhythmia, coronary artery disease, stroke, sympathetic activity, endothelium, inflammation, and continuous positive airway pressure (CPAP) to identify peer-reviewed studies of OSA. Priority was given to large prospective cohort studies and to randomized controlled trials. Data extraction: We identified 154 original investigations and reviews of sleep-related breathing disorders. Data from these studies were examined for relevance and extracted by one of the authors. Data synthesis: Approximately 1 in 5 adults has at least mild OSA (apnea-hypopnea index [ie, the number of apneic and hypopneic events per hour], 5-15), and 1 in 15 adults has at least moderate OSA (apnea-hypopnea index, 15-30). Repetitive apneic events disrupt the normal physiologic interactions between sleep and the cardiovascular system. Such sleep fragmentation, as well as abnormalities evident in patients with OSA (eg, increased sympathetic activation, vascular endothelial dysfunction, increased oxidative stress, inflammation, increased platelet aggregability, metabolic dysregulation), may be implicated in the initiation and progression of cardiac and vascular disease. Persuasive data implicate OSA in the development of hypertension, and OSA also may contribute to cardiac ischemia, congestive heart failure, cardiac arrhythmias, and perhaps also to cerebrovascular disease and stroke. Conclusions: Obstructive sleep apnea is common, readily diagnosed, and usually treatable. It frequently coexists undiagnosed in patients with cardiovascular disease, activates disease mechanisms known to elicit cardiac and vascular damage, and may be implicated in progression of cardiovascular disease and resistance to conventional therapeutic strategies. In the absence of definitive evidence from large-scale trials and a better understanding of potential cost-effectiveness, the likely benefits of diagnosis and treatment of OSA are presently best appraised on an individualized patient basis.

Obstructive sleep apnea remains a risk factor for major adverse cardiovascular and cerebrovascular events even in hypertensive patients under treatment: the Urumqi Research on Sleep Apnea and Hypertension (UROSAH) data

OBSTRUCTIVE SLEEP APNEA REMAINS A RISK FACTOR FOR MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS IN HYPERTENSVIE PATIENTS UNDER TREATMENT: THE UROSAH DATA

The association between blood pressure control and long-term cardiovascular outcomes in Hypertension coexistent with obstructive sleep apnea

Association Between Obstructive Sleep Apnea and Cardiovascular Diseases.

The relationship between obstructive sleep apnea and risk of renal impairment in patients with hypertension, a longitudinal study

Obstructive Sleep Apnea and Cardiovascular Risk in Chinese Population: a Meta-analysis

Influence of Obstructive Sleep Apnea hypopnea Syndrome on Cardiovascular Risk Factors

Associations between common sleep disturbances and cardiovascular risk in patients with obstructive sleep apnea: A large-scale cross-sectional study

Symptom and comorbidity burden in hypertensive patients with obstructive sleep apnea

Efficacy of respiratory intervention on patients with hypertension complicated with obstructive sleep apnea-hypopnea syndrome

Obstructive sleep apnea and cardiovascular disease - time to act!

Effects of Obstructive Sleep Apnea During Rapid Eye Movement Sleep on Cardiac Autonomic Dysfunction: Results from the Shanghai Sleep Health Study Cohort

Obstructive Sleep Apnea and Hypertension: Updates to a Critical Relationship

Clinical outcomes of obstructive sleep apnea in patients with acute coronary syndrome in relation to hyperuricemia status

Association between obstructive sleep apnea and arrhythmia and heart rate variability among hypertensive patients

Characteristics of Hypertension in Obstructive Sleep Apnea: an Asian Experience

Is Obstructive Sleep Apnea Associated With Cardiovascular And All-Cause Mortality?

Cardiovascular consequences of obstructive sleep apnoea

Obstructive sleep apnea syndrome (OSAS) and hypertension: Pathogenic mechanisms and possible therapeutic approaches

Obstructive sleep apnea: implications for cardiac and vascular disease

Factors Affecting Blood Pressure Profile in Pre and Postmenopausal Women with Obstructive Sleep Apnea Hypopnea Syndrome